Explore recruiting clinical trials by treatment type. From cutting-edge immunotherapy to precision-targeted therapies — find studies matching the treatment approach relevant to you.
16 treatment categories with live trial data
Immunotherapy harnesses your body's immune system to fight disease. Unlike chemotherapy which directly attacks cells, im...
10 conditions · Live trials →CAR-T cell therapy is a groundbreaking form of immunotherapy where your own T-cells are genetically modified to express ...
7 conditions · Live trials →Gene therapy treats or cures disease by introducing, altering, or replacing genetic material within your cells. Unlike c...
7 conditions · Live trials →Targeted therapy uses drugs designed to interact with specific molecules involved in cancer growth and progression. Unli...
10 conditions · Live trials →PARP inhibitors are a class of targeted therapy that blocks the PARP (poly-ADP ribose polymerase) enzyme, which cancer c...
5 conditions · Live trials →Antibody-drug conjugates (ADCs) are precision medicines that combine a targeted antibody with a potent chemotherapy payl...
6 conditions · Live trials →Stem cell transplantation replaces damaged or destroyed bone marrow with healthy stem cells that can regenerate the bloo...
7 conditions · Live trials →Chemotherapy uses powerful drugs to kill rapidly dividing cells. Clinical trials explore new combinations, dose schedules, delivery methods, and pairing chemo with immunotherapy or targeted therapy.
14 conditions · Live trials →Radiotherapy uses high-energy radiation to destroy cancer cells. Trials advance proton beam therapy, SBRT, radiopharmaceuticals, and combining radiation with immunotherapy.
12 conditions · Live trials →GLP-1 receptor agonists mimic the action of glucagon-like peptide-1, a hormone that regulates blood sugar, appetite, and...
6 conditions · Live trials →Medicines produced from living organisms including monoclonal antibodies, fusion proteins, and biosimilars. Targeting autoimmune, respiratory, oncology, and rare disease conditions.
14 conditions · Live trials →Treatments that block, add, or modify hormones to treat cancer, endometriosis, menopause, thyroid disorders, and other hormone-sensitive conditions.
10 conditions · Live trials →Oral small-molecule drugs blocking the JAK-STAT inflammatory pathway. Used in rheumatoid arthritis, psoriasis, inflammatory bowel disease, eczema, and haematological conditions.
10 conditions · Live trials →Oral targeted drugs blocking tyrosine kinases that drive cancer cell growth. EGFR, BCR-ABL, VEGFR, ALK, and multi-kinase inhibitors across oncology and haematology.
12 conditions · Live trials →Living cell treatments including CAR-T, TIL therapy, NK cells, dendritic cell vaccines, and stem cell transplants across oncology, haematology, and autoimmune disease.
12 conditions · Live trials →Personalised cancer vaccines (mRNA, peptide, dendritic cell), prophylactic infectious disease vaccines, and combination vaccine strategies. UK is a global leader in vaccine trials.
12 conditions · Live trials →Use our Smart Matcher to find trials based on your condition, biomarkers, and treatment history — it covers all treatment types automatically.